Rastreamento precoce da pré-eclampsia

Translated title of the contribution: Early screening for preeclampsia

Fabrício da Silva Costa, Padma Murthi, Rosemary Keogh, Nicole Woodrow

Research output: Contribution to journalReview ArticleOtherpeer-review

25 Citations (Scopus)


Preeclampsia, which affects about 3 to 5% of pregnant women, is the most frequent medical complication in pregnancy and the most important cause of maternal and perinatal morbidity and mortality. During the past three decades, numerous clinical, biophysical, and biochemical screening tests have been proposed for the early detection of preeclampsia. Literature shows large discrepancies in the sensitivity and predictive value of several of these tests. No single screening test used for preeclampsia prediction has gained widespread acceptance into clinical practice. Instead, its value seems to be in increasing the predictive value of panels of tests, which include other clinical measurements. The aim of this review was to examine the combination of maternal risk factors, mean arterial blood pressure, and uterine artery Doppler, together with biomarkers in the preeclampsia prediction.

Translated title of the contributionEarly screening for preeclampsia
Original languagePortuguese
Pages (from-to)367-375
Number of pages9
JournalRevista Brasileira de Ginecologia e Obstetricia
Issue number11
Publication statusPublished - Nov 2011
Externally publishedYes


  • Biological biomarkers
  • Pre-eclampsia/diagnosis
  • Risk factors
  • Uterine artery/ultrasonography

Cite this